Notice of Request for Public To Submit Comments and Attend Meeting, 61874-61875 [E8-24728]
Download as PDF
<![CDATA[
61874
Federal Register / Vol. 73, No. 202 / Friday, October 17, 2008 / Notices
reference the NIOSH Docket Number
063–A in the subject heading.
Background: NIOSH convened a
similar stakeholders’ meeting in March
2006 to seek input on the progress and
future directions of the FFFIPP. The
input provided by stakeholders at that
meeting was useful in providing insight
into stakeholder needs and in helping to
improve the FFFIPP. The November
2008 meeting will be held to again seek
stakeholder input.
Contact Person for Technical
Information: Paul Moore, Chief, Fatality
Investigations Team, Division of Safety
Research, telephone (304) 285–6016 or
Matt Bowyer, General Engineer, Fatality
Investigations Team, (304) 285–5991.
Dated: October 9, 2008.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E8–24732 Filed 10–16–08; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number NIOSH–144]
Notice of Request for Public To Submit
Comments and Attend Meeting
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice.
sroberts on PROD1PC70 with NOTICES
AGENCY:
SUMMARY: The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the availability of the
following notice of public meeting and
draft document available for public
comment entitled ‘‘NIOSH Criteria
Document Update: Occupational
Exposure to Hexavalent Chromium.’’
The document and instructions for
submitting comments can be found at
https://www.cdc.gov/niosh/review/
public/144/. Comments may be
provided to the NIOSH docket, as well
as given orally at the following meeting.
Public Comment Period: October 15,
2008–January 31, 2009.
Public Meeting Time and Date: 9
a.m.–4 p.m. EST, January 22, 2009.
Place: Robert A. Taft Laboratories,
Taft Auditorium, NIOSH, CDC, 4676
Columbia Parkway, Cincinnati, OH
45226–1998.
VerDate Aug<31>2005
19:18 Oct 16, 2008
Jkt 217001
Purpose of Meeting: To discuss and
obtain comments on the draft document,
‘‘NIOSH Criteria Document Update:
Occupational Exposure to Hexavalent
Chromium.’’ Special emphasis will be
placed on discussion of the following:
1. Are the critical studies presented
clearly and adequately?
2. Do all of the presented studies use
scientifically valid methods and
techniques?
3. Are there additional critical studies
relevant to occupational exposure to
hexavalent chromium compounds that
should be included?
4. Does NIOSH have a transparent and
sound basis for its revised
Recommended Exposure Limit for
hexavalent chromium compounds?
5. Is the new NIOSH policy of
providing general exposure assessment
recommendations instead of a specific
Action Level scientifically justified?
6. Are the NIOSH recommendations
for worker protection clear and
justified?
7. Are there additional
recommendations for worker protection
that should be included?
Status: The forum will include
scientists and representatives from
various government agencies, industry,
labor, and other stakeholders, and is
open to the public, limited only by the
space available. The meeting room
accommodates 80 people. Due to
limited space and security clearance
requirements, notification of intent to
attend the meeting must be made to the
NIOSH Docket Office no later than
January 7, 2009 for U.S. citizens, or no
later than December 30, 2008 for nonU.S. citizens.* Persons wanting to
provide oral comments at the meeting
are requested to notify the NIOSH
Docket Office no later than January 7,
2009 at (513) 533–8611 or by e-mail at
nioshdocket@cdc.gov. Priority for
attendance will be given to those
providing oral comments. Other
requests to attend the meeting will then
be accommodated on a first-come basis.
Unreserved walk-in attendees will not
be admitted due to security clearance
requirements.
Persons wanting to provide oral
comments will be permitted up to 20
minutes. If additional time becomes
available, presenters will be notified.
Oral comments given at the meeting
must also be submitted to the docket in
writing in order to be considered by the
Agency. Written comments will also be
accepted at the meeting. Written
comments may also be submitted to the
NIOSH Docket Office, Robert A. Taft
Laboratories, 4676 Columbia Parkway,
MS C–34, Cincinnati, Ohio 45226,
telephone (513) 533–8611. All material
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
submitted to the Agency should
reference Docket Number NIOSH–144
and must be submitted by January 31,
2009 to be considered by the Agency.
All electronic comments should be
formatted as Microsoft Word. Please
make reference to Docket Number
NIOSH–144.
All information received in response
to this notice will be available for public
examination and copying at the NIOSH
Docket Office, Room 111, 4676
Columbia Parkway, Cincinnati, Ohio
45226.
*Non-U.S. Citizens: Because of CDC
Security Regulations, any non-U.S.
citizen wishing to attend this meeting
must provide the following information
in writing to the NIOSH Docket Officer
at the address below no later than
December 30, 2008. This information
will be transmitted to the CDC Security
Office for approval. Visitors will be
notified as soon as approval has been
obtained.
1. Name:
2. Gender:
3. Date of Birth:
4. Place of Birth (city, province, state,
country):
5. Citizenship:
6. Passport Number:
7. Date of Passport Issue:
8. Date of Passport Expiration:
9. Type of Visa:
10. U.S. Naturalization Number (if a
naturalized citizen)
11. U.S. Naturalization Date (if a
naturalized citizen)
12. Visitor’s Organization:
13. Organization Address:
14. Organization Telephone Number:
15. Visitor’s Position/Title within the
Organization:
Background: This draft NIOSH
document provides a review of the
available literature and provides an
update of NIOSH policies on
occupational exposure to hexavalent
chromium compounds including an
assessment of: (1) Critical animal,
human, and in vitro studies on
occupational exposure to hexavalent
chromium; (2) relevant quantitative risk
assessments about occupational
exposure to hexavalent chromium; (3)
appropriate methods for sampling and
analysis of hexavalent chromium
compounds in the workplace; (4) basis
for the NIOSH revised Recommended
Exposure Limit for hexavalent
chromium compounds; and (5) other
NIOSH recommendations for protecting
workers from occupational exposure to
hexavalent chromium. This guidance
document does not have the force and
effect of law.
The purpose of the public review of
the draft document and public meeting
E:\FR\FM\17OCN1.SGM
17OCN1
Federal Register / Vol. 73, No. 202 / Friday, October 17, 2008 / Notices
is to obtain public comments assessing
whether: (1) This hazard identification
is an accurate reflection of the available
scientific studies; (2) the NIOSH
recommendations for protecting workers
from occupational exposure to
hexavalent chromium compounds are
appropriate and justified, and (3)
NIOSH has a transparent and scientific
basis for its revised Recommended
Exposure Limit for hexavalent
chromium compounds.
CONTACT PERSONS FOR TECHNICAL
INFORMATION: Kathleen MacMahon,
DVM; telephone (513) 533–8547;
Mailstop C–32, Robert A. Taft
Laboratories, 4676 Columbia Parkway,
Cincinnati, OH 45226–1998.
Reference: ‘‘NIOSH Criteria Document
Update: Occupational Exposure to
Hexavalent Chromium’’ (public review
draft). Web address for this document:
https://www.cdc.gov/niosh/review/
public/144/.
Dated: October 9, 2008.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E8–24728 Filed 10–16–08; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Public Meeting and
Availability for Public Comment
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of Public Meeting and
availability for Public Comment.
sroberts on PROD1PC70 with NOTICES
AGENCY:
SUMMARY: The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the opportunity for the
public to provide input regarding the
plan (protocol) for a cohort study of
persons formerly employed at the IBM
facility in Endicott, New York.
Public Meeting Time and Date: 9
a.m.–4 p.m., November 8, 2008.
Place: Broome County Health
Department, 225 Front Street,
Binghamton, New York 13905.
Status: The meeting is open to the
public, limited only by the space
available (the room accommodates
approximately 120 people). Broad
participation is desired. Former
VerDate Aug<31>2005
19:18 Oct 16, 2008
Jkt 217001
workers, representatives of professional
societies, organized labor, employers,
researchers, health professionals, and
government officials are encouraged to
attend. Those who cannot attend in
person are encouraged to e-mail or mail
comments to Dr. Douglas Trout (see
below). Deadline for all comments is
December 8, 2008.
Participants wishing to provide
stakeholder comments may do so via
e-mail or may request an opportunity to
make a five minute presentation.
Participants making a presentation at
the meeting must submit their
comments in writing at the time of the
meeting. All participants (whether
making a presentation or not) must
register for the free meeting by sending
an e-mail to Dr. Douglas Trout at
DTrout@cdc.gov with their name,
affiliation, whether they are requesting
time to speak briefly, and, if so, the
general topic(s) on which they wish to
speak. Participants wishing to speak are
encouraged to register early.
Background: In response to public
interest in the conduct of a study of
cancer among former workers at IBM—
Endicott, NIOSH conducted a feasibility
effort to evaluate whether employee
records were adequate to conduct a
research study (a retrospective cohort
mortality and cancer incidence study).
This study protocol being developed
makes extensive use of the information
gathered during the feasibility effort, as
well as a follow-up review of additional
industrial hygiene, medical, and
personnel records.
The protocol being reviewed
describes the plan for a cohort study of
persons formerly employed at the IBM
facility in Endicott, New York, between
1965 and 2002. The health problems to
be evaluated in the proposed study
include mortality and cancer incidence
among workers, as well as birth defects
among offspring of these workers.
Approximately 28,000 workers were
employed by IBM—Endicott for at least
one year during the period between
1965 and 2002.
The meeting will consist of two parts:
(1) External peer review of the research
protocol. Peer reviewers external to CDC
will be present to provide their
individual technical (scientific) review
comments for the project officers to
maximize the relevance and quality of
the proposed research; and (2)
Stakeholder meeting. The latter part of
the meeting will be structured to hear
stakeholder comments on important
occupational safety and health issues
related to this research.
Contact Person for Technical
Information: Dr. Douglas Trout, MD,
MHS, Associate Director for Science,
PO 00000
Frm 00099
Fmt 4703
Sfmt 4703
61875
Division of Surveillance, Hazard
Evaluations, and Field Studies, NIOSH,
telephone (513) 841–4428. Comments,
meeting registrations, and requests for a
copy of the protocol may be e-mailed to
DTrout@cdc.gov or sent via mail to Dr.
Douglas Trout, NIOSH, 4676 Columbia
Parkway, Mailstop R12, Cincinnati,
Ohio 45226.
Dated: October 9, 2008.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E8–24731 Filed 10–16–08; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Project:
Title: Evaluation of the Community
Healthy Marriage Initiative—Impact
Evaluation Wave 2.
OMB No.: 0970–0322.
Description: The Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS), is conducting a
demonstration and evaluation called the
Community Healthy Marriage Initiative
(CHMI). Demonstration programs have
been funded through Healthy Marriage
and Responsible Fatherhood grants
authorized under section 403(a)(2) of
the Social Security Act to support
healthy marriage directly and to
encourage community changes that
increase support for healthy marriages
and improve child and family wellbeing. The objective of the evaluation is
to: (1) Assess the implementation of
community interventions designed to
provide marriage education by
examining the way the projects operate
and by examining child support
outcomes among low-income families in
the community; and (2) evaluate the
community impacts of these
interventions on marital stability and
satisfaction, child well-being and child
support outcomes among low income
families.
The purpose of this information
collection is to conduct a follow-up
survey of respondents from Wave 1 who
live in the communities where CHMI
demonstrations are operating, and a
survey of CHMI program participants.
The impact evaluation will assess the
effects of community healthy marriage
initiatives by comparing family and
child well-being outcomes in the CHMI
E:\FR\FM\17OCN1.SGM
17OCN1
]]>Agencies
[Federal Register Volume 73, Number 202 (Friday, October 17, 2008)]
[Notices]
[Pages 61874-61875]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-24728]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number NIOSH-144]
Notice of Request for Public To Submit Comments and Attend
Meeting
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC)
announces the availability of the following notice of public meeting
and draft document available for public comment entitled ``NIOSH
Criteria Document Update: Occupational Exposure to Hexavalent
Chromium.'' The document and instructions for submitting comments can
be found at https://www.cdc.gov/niosh/review/public/144/. Comments may
be provided to the NIOSH docket, as well as given orally at the
following meeting.
Public Comment Period: October 15, 2008-January 31, 2009.
Public Meeting Time and Date: 9 a.m.-4 p.m. EST, January 22, 2009.
Place: Robert A. Taft Laboratories, Taft Auditorium, NIOSH, CDC,
4676 Columbia Parkway, Cincinnati, OH 45226-1998.
Purpose of Meeting: To discuss and obtain comments on the draft
document, ``NIOSH Criteria Document Update: Occupational Exposure to
Hexavalent Chromium.'' Special emphasis will be placed on discussion of
the following:
1. Are the critical studies presented clearly and adequately?
2. Do all of the presented studies use scientifically valid methods
and techniques?
3. Are there additional critical studies relevant to occupational
exposure to hexavalent chromium compounds that should be included?
4. Does NIOSH have a transparent and sound basis for its revised
Recommended Exposure Limit for hexavalent chromium compounds?
5. Is the new NIOSH policy of providing general exposure assessment
recommendations instead of a specific Action Level scientifically
justified?
6. Are the NIOSH recommendations for worker protection clear and
justified?
7. Are there additional recommendations for worker protection that
should be included?
Status: The forum will include scientists and representatives from
various government agencies, industry, labor, and other stakeholders,
and is open to the public, limited only by the space available. The
meeting room accommodates 80 people. Due to limited space and security
clearance requirements, notification of intent to attend the meeting
must be made to the NIOSH Docket Office no later than January 7, 2009
for U.S. citizens, or no later than December 30, 2008 for non-U.S.
citizens.* Persons wanting to provide oral comments at the meeting are
requested to notify the NIOSH Docket Office no later than January 7,
2009 at (513) 533-8611 or by e-mail at nioshdocket@cdc.gov. Priority
for attendance will be given to those providing oral comments. Other
requests to attend the meeting will then be accommodated on a first-
come basis. Unreserved walk-in attendees will not be admitted due to
security clearance requirements.
Persons wanting to provide oral comments will be permitted up to 20
minutes. If additional time becomes available, presenters will be
notified. Oral comments given at the meeting must also be submitted to
the docket in writing in order to be considered by the Agency. Written
comments will also be accepted at the meeting. Written comments may
also be submitted to the NIOSH Docket Office, Robert A. Taft
Laboratories, 4676 Columbia Parkway, MS C-34, Cincinnati, Ohio 45226,
telephone (513) 533-8611. All material submitted to the Agency should
reference Docket Number NIOSH-144 and must be submitted by January 31,
2009 to be considered by the Agency. All electronic comments should be
formatted as Microsoft Word. Please make reference to Docket Number
NIOSH-144.
All information received in response to this notice will be
available for public examination and copying at the NIOSH Docket
Office, Room 111, 4676 Columbia Parkway, Cincinnati, Ohio 45226.
*Non-U.S. Citizens: Because of CDC Security Regulations, any non-
U.S. citizen wishing to attend this meeting must provide the following
information in writing to the NIOSH Docket Officer at the address below
no later than December 30, 2008. This information will be transmitted
to the CDC Security Office for approval. Visitors will be notified as
soon as approval has been obtained.
1. Name:
2. Gender:
3. Date of Birth:
4. Place of Birth (city, province, state, country):
5. Citizenship:
6. Passport Number:
7. Date of Passport Issue:
8. Date of Passport Expiration:
9. Type of Visa:
10. U.S. Naturalization Number (if a naturalized citizen)
11. U.S. Naturalization Date (if a naturalized citizen)
12. Visitor's Organization:
13. Organization Address:
14. Organization Telephone Number:
15. Visitor's Position/Title within the Organization:
Background: This draft NIOSH document provides a review of the
available literature and provides an update of NIOSH policies on
occupational exposure to hexavalent chromium compounds including an
assessment of: (1) Critical animal, human, and in vitro studies on
occupational exposure to hexavalent chromium; (2) relevant quantitative
risk assessments about occupational exposure to hexavalent chromium;
(3) appropriate methods for sampling and analysis of hexavalent
chromium compounds in the workplace; (4) basis for the NIOSH revised
Recommended Exposure Limit for hexavalent chromium compounds; and (5)
other NIOSH recommendations for protecting workers from occupational
exposure to hexavalent chromium. This guidance document does not have
the force and effect of law.
The purpose of the public review of the draft document and public
meeting
[[Page 61875]]
is to obtain public comments assessing whether: (1) This hazard
identification is an accurate reflection of the available scientific
studies; (2) the NIOSH recommendations for protecting workers from
occupational exposure to hexavalent chromium compounds are appropriate
and justified, and (3) NIOSH has a transparent and scientific basis for
its revised Recommended Exposure Limit for hexavalent chromium
compounds.
Contact Persons For Technical Information: Kathleen MacMahon, DVM;
telephone (513) 533-8547; Mailstop C-32, Robert A. Taft Laboratories,
4676 Columbia Parkway, Cincinnati, OH 45226-1998.
Reference: ``NIOSH Criteria Document Update: Occupational Exposure
to Hexavalent Chromium'' (public review draft). Web address for this
document: https://www.cdc.gov/niosh/review/public/144/.
Dated: October 9, 2008.
James D. Seligman,
Chief Information Officer, Centers for Disease Control and Prevention.
[FR Doc. E8-24728 Filed 10-16-08; 8:45 am]
BILLING CODE 4163-19-P
